Smith & Wesson Brands (SWBI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for September 17, 2024, to be held virtually; record date is July 26, 2024.
Key agenda items: election of seven directors, advisory vote on executive compensation, and a stockholder proposal regarding a human rights impact assessment.
Board recommends voting for all director nominees, for executive compensation, and against the stockholder proposal.
Major accomplishments include opening a new headquarters in Tennessee and significant progress on board refreshment and governance initiatives.
Voting matters and shareholder proposals
Election of seven directors, all but one of whom are independent; majority voting standard applies.
Advisory say-on-pay vote for executive compensation, with recent high support (97% in 2023).
Stockholder proposal requests a third-party human rights impact assessment; board recommends against, citing cost, redundancy, and prior rejections by shareholders.
Board of directors and corporate governance
Board consists of seven members, six of whom are independent; two women, one racial minority, and one ethnic minority.
Board committees: Audit, Compensation, Nominations and Corporate Governance (NCG), and Sustainability, all comprised of independent directors.
Board refreshment emphasized, with over 70% of directors joining since 2018.
Proxy access and right to call special meetings for holders of 25% of shares.
Over-boarding policy limits directors to three other public company boards.
Latest events from Smith & Wesson Brands
- Q3 net sales up 17.1% to $135.7M, with higher margins and strong Q4 outlook.SWBI
Q3 20265 Mar 2026 - Double-digit growth in revenue and net income, with 2025 outlook for continued gains and higher dividends.SWBI
Q4 20243 Feb 2026 - Q1 sales fell 22.7%, but new products and margin gains support a positive full-year outlook.SWBI
Q1 202522 Jan 2026 - Board re-elections, executive pay approval, and strong financial growth highlighted the meeting.SWBI
AGM 202420 Jan 2026 - Q2 sales up 3.8% to $129.7M, but guidance cut as inflation softens demand and margins.SWBI
Q2 202511 Jan 2026 - Q3 sales fell 15.7% as new products drove 41% of revenue, but margins and sales remain pressured.SWBI
Q3 202527 Dec 2025 - Q2 sales dipped 3.9% but cash flow and new product momentum support a strong Q3 outlook.SWBI
Q2 20267 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.SWBI
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with focus on governance and performance.SWBI
Proxy Filing1 Dec 2025